Our Noviplex cards have been relaunched and rebranded!
Visit our Telimmune™ website to learn more and purchase today.
SOLUTIONS
CONVERT LCs INTO PROTEOFORM METERS
Proteometer Kit - Coming Early 2023
World's first technology for at-line molecular structure analysis
NOVIPLEX™ PLASMA COLLECTION SOLUTIONS
(NOW TELIMMUNE)
Advanced Remote
Plasma Collection
Availible at Telimmune.com
ENHANCED APPROACH TO PROCESS ANALYTICAL TECHNOLOGY
MASC®, Sequestron®, Luminon®
Learn about the technology & components behind Proteometer Kits
ABOUT
Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
--
A canary in a coal mine saved the lives of hundreds of miners. Novilytic takes this same premise and applies it to medicines developed in modern drug bioreactors (fermenters).
By recognizing molecular structure early and often, we can help ensure quality and consistency.
Existing methods take 4-8 hours to evaluate medication quality. Our technology performs this task in an average of 10 minutes. The results allow pharmaceutical companies to alter their batches’ process parameters in a timely manner and keep them compliant with regulatory bodies.
We call this patented technology "The Proteometer," which is short for Proteoform Meter.
TESTIMONIALS
“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”
Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)
“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”
Ines Macias-Perez, Ph.D
Principle Scientist, Product Development
Cumberland Pharmaceuticals
> 5,000
Bioreactors Globally
$8M
Raw Material Costs
0 PAT In-Line
Massive Industry Gap
The Proteometer Provides the Solution